pI: 9.0929 |
Length (AA): 899 |
MW (Da): 105030 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 9 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
171 | 780 | 1s2m (A) | 46 | 422 | 24.00 | 0 | 1 | 0.19 | 0.77 |
172 | 353 | 1fuu (B) | 22 | 190 | 31.00 | 0.00000000023 | 1 | 0.72 | -1.89 |
3 | 47 | 1llm (C) | 111 | 155 | 11.00 | 0.00031 | 0 | 0.241556 | -1.1 |
162 | 371 | 2pl3 (A) | 57 | 262 | 36.00 | 0 | 1 | 0.720793 | -1.06 |
164 | 356 | 3eiq (A) | 26 | 203 | 38.00 | 0.0000000000055 | 1 | 0.626883 | -0.61 |
179 | 764 | 3i5x (A) | 112 | 497 | 31.00 | 0 | 1 | 0.381035 | 1.12 |
622 | 762 | 1hv8 (A) | 216 | 356 | 25.00 | 0.027 | 0.73 | 0.507741 | -0.5 |
669 | 762 | 1s2m (A) | 308 | 401 | 27.00 | 0.93 | 0.98 | 0.427461 | 0.23 |
690 | 761 | 2jgn (A) | 486 | 554 | 40.00 | 0.15 | 0.72 | 0.266289 | 1.37 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, merozoite, sporozoite, early ring, early trophozoite, late ring, late trophozoite, Ring, Sporozoite. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | early schizont, Oocyst, Male Gametocyte. | PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, gametocyte, late schizont, Female Gametocyte. | Otto TD PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 48 hs. | Otto TD |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_128340)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G40700 | DEAD-box ATP-dependent RNA helicase 17 |
Babesia bovis | BBOV_IV009500 | DEAD/DEAH box helicase protein family |
Candida albicans | CaO19_6902 | hypothetical protein |
Candida albicans | CaO19.6902 | ATP-dependent RNA helicase |
Cryptosporidium hominis | Chro.40207 | CG8611-PB |
Cryptosporidium parvum | cgd4_1840 | Dbp7p, eIF4A-a-family RNA SFII helicase (DEXDc+HELICc) |
Dictyostelium discoideum | DDB_G0271708 | DEAD/DEAH box helicase |
Drosophila melanogaster | Dmel_CG8611 | CG8611 gene product from transcript CG8611-RB |
Echinococcus granulosus | EgrG_000110700 | ATP dependent RNA helicase DDX31 |
Entamoeba histolytica | EHI_165110 | DEAD/DEAH box helicase, putative |
Echinococcus multilocularis | EmuJ_000110700 | ATP dependent RNA helicase DDX31 |
Giardia lamblia | GL50803_16042 | ATP-dependent RNA helicase |
Homo sapiens | ENSG00000125485 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 |
Leishmania braziliensis | LbrM.27.0060 | DEAD-box helicase-like protein |
Leishmania donovani | LdBPK_270050.1 | DEAD-box helicase-like protein |
Leishmania infantum | LinJ.27.0050 | DEAD-box helicase-like protein |
Leishmania major | LmjF.27.0050 | DEAD-box helicase-like protein |
Leishmania mexicana | LmxM.27.0050 | DEAD-box helicase-like protein |
Mus musculus | ensembl-mmu:ENSMUSG00000026806 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 31 |
Neospora caninum | NCLIV_066580 | ATP-dependent RNA helicase, putative |
Oryza sativa | 4337589 | Os05g0110500 |
Plasmodium berghei | PBANKA_0618800 | ATP-dependent RNA helicase DBP7, putative |
Plasmodium falciparum | PF3D7_0721300 | ATP-dependent RNA helicase DBP7, putative |
Plasmodium knowlesi | PKNH_0316700 | ATP-dependent RNA helicase DBP7, putative |
Plasmodium vivax | PVX_096271 | conserved Plasmodium protein, unknown function |
Plasmodium vivax | PVX_096273 | DEAD/DEAH box ATP-dependent RNA helicase, putative |
Plasmodium yoelii | PY04724 | Drosophila melanogaster BcDNA.GH02833 |
Saccharomyces cerevisiae | YKR024C | Dbp7p |
Schistosoma japonicum | Sjp_0117640 | expressed protein |
Schistosoma japonicum | Sjp_0082780 | Probable ATP-dependent RNA helicase DDX31, putative |
Schistosoma japonicum | Sjp_0025770 | Probable ATP-dependent RNA helicase DDX31, putative |
Schistosoma mansoni | Smp_057020 | DEAD box ATP-dependent RNA helicase |
Schmidtea mediterranea | mk4.015775.00 | |
Schmidtea mediterranea | mk4.019158.01 | Probable ATP-dependent RNA helicase DDX31 |
Trypanosoma brucei gambiense | Tbg972.3.230 | ATP-dependent DEAD/H RNA helicase, putative |
Trypanosoma brucei | Tb927.3.620 | ATP-dependent DEAD/H RNA helicase, putative |
Trypanosoma congolense | TcIL3000_0_07370 | ATP-dependent DEAD/H RNA helicase, putative |
Trypanosoma cruzi | TcCLB.509719.20 | ATP-dependent DEAD/H RNA helicase, putative |
Trypanosoma cruzi | TcCLB.506713.30 | ATP-dependent DEAD/H RNA helicase, putative |
Toxoplasma gondii | TGME49_251480 | DEAD/DEAH box helicase domain-containing protein |
Theileria parva | TP01_0822 | DEAD box RNA helicase, putative |
Trichomonas vaginalis | TVAG_314580 | DEAD box ATP-dependent RNA helicase, putative |
Trichomonas vaginalis | TVAG_314600 | DEAD box ATP-dependent RNA helicase, putative |
Trichomonas vaginalis | TVAG_004080 | DEAD box ATP-dependent RNA helicase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.620 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.620 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.620 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.620 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_0618800 | Plasmodium berghei | Slow | plasmo |
TGME49_251480 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
2 literature references were collected for this gene.